Cerebral amyloid angiopathy and intracerebral haemorrhage: community-based cohort study, biobank, and record linkage
In plain English
AI plain-English summaryA protein called amyloid gradually damages the blood vessels in the brains of some elderly people, putting them at risk of a stroke caused by bleeding inside the skull. This condition—cerebral amyloid angiopathy, or CAA—is poorly understood. Doctors cannot reliably predict who will have a brain haemorrhage, what causes it, or whether someone who survives one will have another. The research will follow a community-based group of adults who have had a brain haemorrhage, collecting their brain scans, tissue samples, and medical records. By comparing them with people who have not had a haemorrhage, and by linking their data to national health records, the team aims to identify the biological markers and risk factors that distinguish CAA-related bleeds from other types. If the research succeeds, it could lead to better diagnostic tools for identifying CAA in living patients and more accurate predictions of who is likely to suffer a second haemorrhage. That would help clinicians decide on treatments and preventive strategies. Because the population is ageing, the number of people with CAA-related brain haemorrhages is expected to rise, making this work increasingly relevant to stroke care and public health planning.
View original technical description
View the original record at the funder ↗
Researchers
Related Research
Grants with similar aims, by meaning.
Original classification
FellowshipPlain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research. Is something wrong? Let us know